Related Experiment Videos
Identification of an occludin cell adhesion recognition sequence.
Orest W Blaschuk1, Tadayuki Oshima, Barbara J Gour
1Department of Surgery, Royal Victoria Hospital, Montreal, Quebec, Canada.
Inflammation
|August 20, 2002
Summary
Researchers identified a specific amino acid sequence (LYHY) in occludin, a protein crucial for cell adhesion and barrier function. This finding reveals key molecular mechanisms underlying endothelial cell barrier integrity.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- The precise molecular mechanisms of occludin, a tight junction protein, in promoting cell adhesion and forming endothelial permeability barriers remain unclear.
- Specific occludin cell adhesion recognition (CAR) sites have not been identified, hindering a deeper understanding of endothelial barrier function.
Purpose of the Study:
- To elucidate the molecular mechanisms of occludin-mediated cell adhesion and endothelial barrier formation.
- To determine the specific amino acid sequences responsible for occludin cell adhesion recognition (CAR).
Main Methods:
- Synthesis and application of a cyclic peptide containing the LYHY sequence.
- In vitro assays to assess the inhibition of endothelial cell barrier establishment.
- In vivo studies to evaluate the effect on endothelial barrier integrity.
- Fibroblast aggregation assays using cells transfected with occludin cDNA.
Main Results:
- A cyclic peptide mimicking the LYHY sequence, found in occludin's extracellular domain, inhibited endothelial barrier formation both in vitro and in vivo.
- This LYHY-containing peptide also prevented the aggregation of occludin-expressing fibroblasts.
- These findings strongly suggest that the LYHY motif constitutes an occludin CAR site.
Conclusions:
- The LYHY motif within occludin functions as a critical cell adhesion recognition (CAR) site.
- Understanding this motif's role is vital for elucidating occludin's function in endothelial barrier integrity.
- This discovery opens new avenues for therapeutic strategies targeting endothelial permeability.